# DIACETYLATED MONOGLYCERIDES

URL: https://app.greenveil.ai/ingredients/ingredient_unii_5_z17386_usf
Categories: pharma
Identifier: cfr:21 CFR 172.828

> DIACETYLATED MONOGLYCERIDES. Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 4 mg Assessed from 11 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 4 mg

## Regulatory status

- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1728 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 189 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.63 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 51 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 2.48 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 12 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._